BRD2 and neoplasm: Only two proteins—DEFA1 (elevated in tumors) and LYZ (significantly decreased in tumors)—could robustly differentiate disease recurrence, whereas the authors found lipid profiles were more discriminatory for disease recurrence in addition to discriminating tumor versus NAT.